What amount sold does Solo-Dex, Inc. report in Form D filings?

The latest linked filings report $35K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Solo-Dex, Inc.'s most recent SEC filing?

Solo-Dex, Inc.'s most recent Form D filing was on 2025-07-22.

How many investors does Solo-Dex, Inc. have?

The most recent Form D filing lists 2 investor(s).

Solo-Dex, Inc.

CIK: 0001816580·Biotechnology·WOLF CREEK, MT·Corporation

Reported Sold

$35,199

Total Filings

Identified Offerings

Last Filed

Jul 22, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jul 22, 2025Form D — New notice

Reported sold: $35,199 · Target: $3,600,000

Rule 506(c)·2 investors

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$35,199

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

STEVEN EROR

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 22, 2025	New	$3,600,000	$35,199	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Swep Bio, Inc.

Biotechnology

Offering target: $4,999,976

Filed Oct 29, 2026